Embecta EV/EBIT EMBC

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2022.

Today, Oct 23, 2026: 6.7×
4-year median: 8.8×
Against its 4-year history: 21st; percentile: 0 is its lowest day, 100 its highest
4-year range: 4.8× to 14.4×
Peer median: 22.8×

Embecta's EV/EBIT is 6.7× as of Oct 23, 2026.

That is below its 4-year median of 8.8×, lower than on 79% of days in the last 4 years.

Over that time it ranged from 4.8× in Jun 2026 to 14.4× in Dec 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 22.8×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	6.7×	4.8×	6.9×
2025	6.8×	6.7×	14.3×
2024	14.4×	9.9×	14.4×
2023	10.4×	7.0×	10.4×
2022	7.4×	7.4×	7.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Embecta's size, closest first, today.

Company	EV/EBIT
EMBCEmbecta	6.7×
INFUInfuSystem	22.4×
TCMDTactile Systems Technology	13.3×
MDXGMimedx	51.6×
UTMDUtah Medical Products	6.0×
MOVMovado	11.8×
PDEXPro DEX	16.0×
IRMDIradimed	37.7×
STAAStaar Surgical	57.7×
BVSBioventus	26.2×
CDRECadre	23.2×
Peer median	22.8×

Where Embecta ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Embecta

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.